What the Evidence Covers
No cannabis product is FDA-approved to treat multiple sclerosis. The closest product is nabiximols, sold as Sativex. It is an oral spray with a 1:1 ratio of THC to CBD. Regulators in Canada, the UK, and several EU countries approved it for MS spasticity. It is not sold in the US.
The American Academy of Neurology 2014 guideline states that oral cannabis extract is probably effective for patient-reported spasticity and central pain in MS. The same guideline called evidence for smoked cannabis insufficient. A 2020 trial called MUSEC found no gain on its main spasticity measure at 12 weeks. Some secondary measures favored the drug. Keep that gap in mind when a strain name promises relief.
how to get medical cannabis for ms
First Pick: A 1:1 THC to CBD Chemovar
Start here. A 1:1 ratio is the profile tested in the trials. Nabiximols delivers about 2.7 mg THC and 2.5 mg CBD per spray. Trial doses reached 12 sprays per day, or about 32 mg THC.
- Cannatonic: labs range from 1:1 to 2:1 CBD to THC. Ask for the certificate of analysis.
- Pennywise: listed near 1:1, often 10% to 15% THC and CBD each.
- Harlequin: often 5:2 CBD to THC. The ratio shifts by grower.
- Warlock: less common, sold in some US markets as a 1:1.
Strain names are marketing. Two jars with the same name can test at different ratios. The lab report matters more than the name on the lid.
CBD-Dominant Options for Low THC
These carry less impairment. The tradeoff: CBD alone has thin evidence for MS spasticity. Epidiolex, a purified CBD drug, is FDA-approved for seizures in two epilepsy syndromes, not for MS.
- AC/DC: some lots test at 20:1 CBD to THC, with THC under 1%.
- Charlotte's Web: bred for low THC, high CBD.
- Sour Tsunami: often 2:1 CBD to THC or higher.
- Harle-Tsu: a cross of Harlequin and Sour Tsunami, high CBD.
High-THC Options and Their Limits
Flower above 20% THC raises the odds of anxiety, sedation, and short-term memory effects. If you try one, start at 1 mg to 2 mg THC.
- Northern Lights: sedating, often 16% to 21% THC.
- Blue Dream: hybrid, often 17% to 24% THC.
- OG Kush: often 19% to 26% THC.
None of these carries a 1:1 ratio. They do not match the product used in MS trials.
Format Decides Dose, Not the Strain Name
Convenience shapes the outcome. A tincture with a 1 mg dropper gives a repeatable dose. A joint does not. Options to compare:
- Metered oral spray or sublingual tincture: dose in milligrams, onset in 15 to 60 minutes.
- Capsule or softgel: no taste, slow onset, 1 to 3 hours.
- Vaporizer cartridge: onset in minutes, dose control depends on the device.
- Flower: hardest to dose, fastest onset when smoked.
Pick the format first. Then pick the ratio. Then pick the strain.
Checklist Before You Buy
- Confirm MS is a qualifying condition in your state. Most US medical programs list it.
- Ask for the certificate of analysis. Check THC, CBD, and terpenes.
- Note the harvest date. Terpenes fade with time.
- Log dose, time, and symptoms for two weeks.
- Tell your neurologist. Cannabis can interact with baclofen, opioids, and some anti-seizure drugs.
Bottom Line
A 1:1 THC to CBD chemovar in a metered format comes first. CBD-dominant strains are the lower-risk second option. High-THC strains are third. Nabiximols is the only cannabis-derived MS drug with regulatory approval, and it is not available in the US. Strain names vary by grower, so buy on lab numbers, not labels.